Thomas Van Cann
Impact in
- Oncology top 10%
- Bone health and treatments
- Cancer Diagnosis and Treatment
- Vascular Tumors and Angiosarcomas
- Orthopedics and Sports Medicine top 10%
- Bone and Joint Diseases
Papers in
- Oncology 7
- Vascular Tumors and Angiosarcomas 3
- Bone health and treatments 3
-
- Sarcoma Diagnosis and Treatment 5
- Co-authors
- Patrick Schöffski (10 shared papers)Agnieszka Woźniak (5 shared papers)Raf Sciot (6 shared papers)Maria Dêbiec‐Rychter (5 shared papers)Jasmien Cornillie (5 shared papers)Herlinde Dumez (3 shared papers)Benoit Beuselinck (3 shared papers)Ludo Willems (2 shared papers)
- Journals
- Journal of Clinical Oncology (1 paper)Supportive Care in Cancer (1 paper)Expert Review of Anticancer Therapy (1 paper)The Lancet Respiratory Medicine (1 paper)Cancer Research (1 paper)
- Partner nations
- BelgiumNetherlandsUnited Kingdom
In The Last Decade
Thomas Van Cann
11 papers receiving 377 citations
Peers
Comparison fields: 5 of 41
- Oncology 212
- Orthopedics and Sports Medicine 59
- Rheumatology 88
- Pulmonary and Respiratory Medicine 131
- Gastroenterology 11
Countries citing papers authored by Thomas Van Cann
This map shows the geographic impact of Thomas Van Cann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Van Cann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Van Cann more than expected).
Fields of papers citing papers by Thomas Van Cann
This network shows the impact of papers produced by Thomas Van Cann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Van Cann. The network helps show where Thomas Van Cann may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas Van Cann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 125 | |
| 2 | 2012 | 86 | |
| 3 | 2017 | 45 | |
| 4 | 2017 | 43 | |
| 5 | 2016 | 28 | |
| 6 | 2017 | 21 | |
| 7 | 2019 | 17 | |
| 8 | 2021 | 7 | |
| 9 | 2017 | 4 | |
| 10 | 2018 | 2 | |
| 11 | 2017 | 2 |
About Thomas Van Cann
Thomas Van Cann is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine, Cardiology and Cardiovascular Medicine and Surgery, having authored 11 papers that have together received 380 indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (5 papers), Vascular Tumors and Angiosarcomas (3 papers), Bone health and treatments (3 papers), Soft tissue tumors and treatment (2 papers), Cardiac tumors and thrombi (2 papers), IgG4-Related and Inflammatory Diseases (1 paper), Lymphoma Diagnosis and Treatment (1 paper) and Neuroendocrine Tumor Research Advances (1 paper). The work is most often cited by research in Oncology (212 citations), Orthopedics and Sports Medicine (59 citations), Rheumatology (88 citations), Pulmonary and Respiratory Medicine (131 citations) and Gastroenterology (11 citations). Thomas Van Cann has collaborated with scholars based in Belgium, Netherlands and United Kingdom. Frequent co-authors include Patrick Schöffski, Agnieszka Woźniak, Raf Sciot, Maria Dêbiec‐Rychter, Jasmien Cornillie, Herlinde Dumez, Benoit Beuselinck, Ludo Willems, Philip R. Debruyne and Lars H. Lindner. Their work appears in journals such as Journal of Clinical Oncology, Supportive Care in Cancer, Expert Review of Anticancer Therapy, The Lancet Respiratory Medicine and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.